Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. SWOT Analysis-Coronary Artery Disease Market

5.1 Strength
5.2 Weakness
5.3 Opportunity
5.4 Threat


6. Porter’s Five Forces

6.1 Bargaining Power of Buyers
6.2 Bargaining Power of Suppliers
6.3 Degree of Competition
6.4 Threat of New Entrants
6.5 Threat of Substitutes


7. Coronary Artery Disease Market-8MM


8. Market Share – Coronary Artery Disease Analysis

8.1 By Country (8 Major Markets)
8.2 By Drug Type
8.3 By Distribution Channel


9. Country – Coronary Artery Disease Market

9.1 United States

9.1.1 Prevalence Rate
9.1.2 Population

9.1.2.1 Coronary Artery Disease Population
9.1.2.2 Physician Visiting - CAD Population

9.1.3 Price Analysis
9.1.4 CAD Mortality Analysis
9.1.5 Market

9.2 France

9.2.1 Prevalence Rate
9.2.2 Population

9.2.2.1 Coronary Artery Disease Population
9.2.2.2 Physician Visiting - CAD Population

9.2.3 Price Analysis
9.2.4 CAD Mortality Analysis
9.2.5 Market

9.3 Germany

9.3.1 Prevalence Rate
9.3.2 Population

9.3.2.1 Coronary Artery Disease Population
9.3.2.2 Physician Visiting - CAD Population

9.3.3 Price Analysis
9.3.4 CAD Mortality Analysis
9.3.5 Market

9.4 China

9.4.1 Prevalence Rate
9.4.2 Population

9.4.2.1 Coronary Artery Disease Population
9.4.2.2 Physician Visiting - CAD Population

9.4.3 Price Analysis
9.4.4 CAD Mortality Analysis
9.4.5 Market

9.5 United Kingdom

9.5.1 Prevalence Rate
9.5.2 Population

9.5.2.1 Coronary Artery Disease Population
9.5.2.2 Physician Visiting - CAD Population

9.5.3 Price Analysis
9.5.4 CAD Mortality Analysis
9.5.5 Market

9.6 Japan

9.6.1 Prevalence Rate
9.6.2 Population

9.6.2.1 Coronary Artery Disease Population
9.6.2.2 Physician Visiting - CAD Population

9.6.3 Price Analysis
9.6.4 CAD Mortality Analysis
9.6.5 Market

9.7 Saudi Arabia

9.7.1 Prevalence Rate
9.7.2 Population

9.7.2.1 Coronary Artery Disease Population
9.7.2.2 Physician Visiting - CAD Population

9.7.3 Price Analysis
9.7.4 CAD Mortality Analysis
9.7.5 Market

9.8 Russia

9.8.1 Prevalence Rate
9.8.2 Population

9.8.2.1 Coronary Artery Disease Population
9.8.2.2 Physician Visiting - CAD Population

9.8.3 Price Analysis
9.8.4 CAD Mortality Analysis
9.8.5 Market


10. Drug Type-Coronary Artery Disease Market

10.1 Anti Platelets
10.2 Beta Blockers
10.3 Calcium Antagonists
10.4 Anticoagulants
10.5 Others


11. Distribution Channel- Coronary Artery Disease Market

11.1 Hospital Pharmacies
11.2 Retail Pharmacies
11.3 Online Pharmacies


12. Clinical Trials Drugs-Coronary Artery Disease

12.1 Colchicine
12.2 Rivaroxaban 2.5 Mg Oral Tablet


13. Key Players Analysis

13.1 AstraZeneca Plc

13.1.1 Company overview
13.1.2 Sales Analysis
13.1.3 Recent Development

13.2 Novartis AG

13.2.1 Company overview
13.2.2 Sales Analysis
13.2.3 Recent Development

13.3 Pfizer Inc.

13.3.1 Company overview
13.3.2 Sales Analysis
13.3.3 Recent Development

13.4 Bristol-Myers Squibb Company

13.4.1 Company overview
13.4.2 Sales Analysis
13.4.3 Recent Development

13.5 Merck & Co., Inc

13.5.1 Company overview
13.5.2 Sales Analysis
13.5.3 Recent Development

13.6 Viatris

13.6.1 Company overview
13.6.2 Sales Analysis
13.6.3 Recent Development

13.7 Sanofi

13.7.1 Company overview
13.7.2 Sales Analysis
13.7.3 Recent Development

13.8 Amgen

13.8.1 Company overview
13.8.2 Sales Analysis
13.8.3 Recent Development



List of Figures

Figure-01: Global – Coronary Artery Disease Market (Billion US$), 2018 – 2022
Figure-02: Global – Forecast for Coronary Artery Disease Market (Billion US$), 2023 – 2028
Figure-03: United States – Prevalence Rate (Percent), 2018 – 2022
Figure-04: United States – Forecast for Prevalence Rate (Percent), 2023 – 2028
Figure-05: United States – Coronary Artery Disease Population (Number), 2018 – 2022
Figure-06: United States – Forecast for Coronary Artery Disease Population (Number), 2023 – 2028
Figure-07: United States – Physician Visiting - CAD Population (Number), 2018 – 2022
Figure-08: United States – Forecast for Physician Visiting - CAD Population (Number), 2023 – 2028
Figure-09: United States – Price Analysis (US$), 2018 – 2022
Figure-10: United States – Forecast for Price Analysis (US$), 2023 – 2028
Figure-11: United States – CAD Mortality (Number), 2018 – 2022
Figure-12: United States – Forecast for CAD Mortality (Number), 2023 – 2028
Figure-13: United States – Coronary Artery Disease Market (Million US$), 2018 – 2022
Figure-14: United States – Forecast for Coronary Artery Disease Market (Million US$), 2023 – 2028
Figure-15: France – Prevalence Rate (Percent), 2018 – 2022
Figure-16: France – Forecast for Prevalence Rate (Percent), 2023 – 2028
Figure-17: France – Coronary Artery Disease Population (Number), 2018 – 2022
Figure-18: France – Forecast for Coronary Artery Disease Population (Number), 2023 – 2028
Figure-19: France – Physician Visiting - CAD Population (Number), 2018 – 2022
Figure-20: France – Forecast for Physician Visiting - CAD Population (Number), 2023 – 2028
Figure-21: France – Price Analysis (US$), 2018 – 2022
Figure-22: France – Forecast for Price Analysis (US$), 2023 – 2028
Figure-23: France – CAD Mortality (Number), 2018 – 2022
Figure-24: France – Forecast for CAD Mortality (Number), 2023 – 2028
Figure-25: France – Coronary Artery Disease Market (Million US$), 2018 – 2022
Figure-26: France – Forecast for Coronary Artery Disease Market (Million US$), 2023 – 2028
Figure-27: Germany – Prevalence Rate (Percent), 2018 – 2022
Figure-28: Germany – Forecast for Prevalence Rate (Percent), 2023 – 2028
Figure-29: Germany – Coronary Artery Disease Population (Number), 2018 – 2022
Figure-30: Germany – Forecast for Coronary Artery Disease Population (Number), 2023 – 2028
Figure-31: Germany – Physician Visiting - CAD Population (Number), 2018 – 2022
Figure-32: Germany – Forecast for Physician Visiting - CAD Population (Number), 2023 – 2028
Figure-33: Germany – Price Analysis (US$), 2018 – 2022
Figure-34: Germany – Forecast for Price Analysis (US$), 2023 – 2028
Figure-35: Germany – CAD Mortality (Number), 2018 – 2022
Figure-36: Germany – Forecast for CAD Mortality (Number), 2023 – 2028
Figure-37: Germany – Coronary Artery Disease Market (Million US$), 2018 – 2022
Figure-38: Germany – Forecast for Coronary Artery Disease Market (Million US$), 2023 – 2028
Figure-39: China – Prevalence Rate (Percent), 2018 – 2022
Figure-40: China – Forecast for Prevalence Rate (Percent), 2023 – 2028
Figure-41: China – Coronary Artery Disease Population (Number), 2018 – 2022
Figure-42: China – Forecast for Coronary Artery Disease Population (Number), 2023 – 2028
Figure-43: China – Physician Visiting - CAD Population (Number), 2018 – 2022
Figure-44: China – Forecast for Physician Visiting - CAD Population (Number), 2023 – 2028
Figure-45: China – Price Analysis (US$), 2018 – 2022
Figure-46: China – Forecast for Price Analysis (US$), 2023 – 2028
Figure-47: China – CAD Mortality (Number), 2018 – 2022
Figure-48: China – Forecast for CAD Mortality (Number), 2023 – 2028
Figure-49: China – Coronary Artery Disease Market (Million US$), 2018 – 2022
Figure-50: China – Forecast for Coronary Artery Disease Market (Million US$), 2023 – 2028
Figure-51: United Kingdom – Prevalence Rate (Percent), 2018 – 2022
Figure-52: United Kingdom – Forecast for Prevalence Rate (Percent), 2023 – 2028
Figure-53: United Kingdom – Coronary Artery Disease Population (Number), 2018 – 2022
Figure-54: United Kingdom – Forecast for Coronary Artery Disease Population (Number), 2023 – 2028
Figure-55: United Kingdom – Physician Visiting - CAD Population (Number), 2018 – 2022
Figure-56: United Kingdom – Forecast for Physician Visiting - CAD Population (Number), 2023 – 2028
Figure-57: United Kingdom – Price Analysis (US$), 2018 – 2022
Figure-58: United Kingdom – Forecast for Price Analysis (US$), 2023 – 2028
Figure-59: United Kingdom – CAD Mortality (Number), 2018 – 2022
Figure-60: United Kingdom – Forecast for CAD Mortality (Number), 2023 – 2028
Figure-61: United Kingdom – Coronary Artery Disease Market (Million US$), 2018 – 2022
Figure-62: United Kingdom – Forecast for Coronary Artery Disease Market (Million US$), 2023 – 2028
Figure-63: Japan – Prevalence Rate (Percent), 2018 – 2022
Figure-64: Japan – Forecast for Prevalence Rate (Percent), 2023 – 2028
Figure-65: Japan – Coronary Artery Disease Population (Number), 2018 – 2022
Figure-66: Japan – Forecast for Coronary Artery Disease Population (Number), 2023 – 2028
Figure-67: Japan – Physician Visiting - CAD Population (Number), 2018 – 2022
Figure-68: Japan – Forecast for Physician Visiting - CAD Population (Number), 2023 – 2028
Figure-69: Japan – Price Analysis (US$), 2018 – 2022
Figure-70: Japan – Forecast for Price Analysis (US$), 2023 – 2028
Figure-71: Japan – CAD Mortality (Number), 2018 – 2022
Figure-72: Japan – Forecast for CAD Mortality (Number), 2023 – 2028
Figure-73: Japan – Coronary Artery Disease Market (Million US$), 2018 – 2022
Figure-74: Japan – Forecast for Coronary Artery Disease Market (Million US$), 2023 – 2028
Figure-75: Saudi Arabia – Prevalence Rate (Percent), 2018 – 2022
Figure-76: Saudi Arabia – Forecast for Prevalence Rate (Percent), 2023 – 2028
Figure-77: Saudi Arabia – Coronary Artery Disease Population (Number), 2018 – 2022
Figure-78: Saudi Arabia – Forecast for Coronary Artery Disease Population (Number), 2023 – 2028
Figure-79: Saudi Arabia – Physician Visiting - CAD Population (Number), 2018 – 2022
Figure-80: Saudi Arabia – Forecast for Physician Visiting - CAD Population (Number), 2023 – 2028
Figure-81: Saudi Arabia – Price Analysis (US$), 2018 – 2022
Figure-82: Saudi Arabia – Forecast for Price Analysis (US$), 2023 – 2028
Figure-83: Saudi Arabia – CAD Mortality (Number), 2018 – 2022
Figure-84: Saudi Arabia – Forecast for CAD Mortality (Number), 2023 – 2028
Figure-85: Saudi Arabia – Coronary Artery Disease Market (Million US$), 2018 – 2022
Figure-86: Saudi Arabia – Forecast for Coronary Artery Disease Market (Million US$), 2023 – 2028
Figure-87: Russia – Prevalence Rate (Percent), 2018 – 2022
Figure-88: Russia – Forecast for Prevalence Rate (Percent), 2023 – 2028
Figure-89: Russia – Coronary Artery Disease Population (Number), 2018 – 2022
Figure-90: Russia – Forecast for Coronary Artery Disease Population (Number), 2023 – 2028
Figure-91: Russia – Physician Visiting - CAD Population (Number), 2018 – 2022
Figure-92: Russia – Forecast for Physician Visiting - CAD Population (Number), 2023 – 2028
Figure-93: Russia – Price Analysis (US$), 2018 – 2022
Figure-94: Russia – Forecast for Price Analysis (US$), 2023 – 2028
Figure-95: Russia – CAD Mortality (Number), 2018 – 2022
Figure-96: Russia – Forecast for CAD Mortality (Number), 2023 – 2028
Figure-97: Russia – Coronary Artery Disease Market (Million US$), 2018 – 2022
Figure-98: Russia – Forecast for Coronary Artery Disease Market (Million US$), 2023 – 2028
Figure-99: Drug Type – Anti Platelets (Percent), 2018 – 2022
Figure-100: Drug Type – Forecast for Anti Platelets (Percent), 2023 – 2028
Figure-101: Drug Type – Beta Blockers (Number), 2018 – 2022
Figure-102: Drug Type – Forecast for Beta Blockers (Number), 2023 – 2028
Figure-103: Drug Type – Calcium Antagonists (Number), 2018 – 2022
Figure-104: Drug Type – Forecast for Calcium Antagonists (Number), 2023 – 2028
Figure-105: Drug Type – Anticoagulants (US$), 2018 – 2022
Figure-106: Drug Type – Forecast for Anticoagulants (US$), 2023 – 2028
Figure-107: Drug Type – Others (Number), 2018 – 2022
Figure-108: Drug Type – Forecast for Others (Number), 2023 – 2028
Figure-109: Distribution Channel – Hospital Pharmacies Market (Million US$), 2018 – 2022
Figure-110: Distribution Channel – Forecast for Hospital Pharmacies Market (Million US$), 2023 – 2028
Figure-111: Distribution Channel – Retail Pharmacies Market (Million US$), 2018 – 2022
Figure-112: Distribution Channel – Forecast for Retail Pharmacies Market (Million US$), 2023 – 2028
Figure-113: Distribution Channel – Online Pharmacies Market (Million US$), 2018 – 2022
Figure-114: Distribution Channel – Forecast for Online Pharmacies Market (Million US$), 2023 – 2028
Figure-115: AstraZeneca Plc – Global Revenue (Billion US$), 2018 – 2022
Figure-116: AstraZeneca Plc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-117: Novartis AG – Global Revenue (Billion US$), 2018 – 2022
Figure-118: Novartis AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-119: Pfizer Inc. – Global Revenue (Billion US$), 2018 – 2022
Figure-120: Pfizer Inc. – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-121: Bristol-Myers Squibb Company – Global Revenue (Million US$), 2018 – 2022
Figure-122: Bristol-Myers Squibb Company – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-123: Merck & Co., Inc – Global Revenue (Billion US$), 2018 – 2022
Figure-124: Merck & Co., Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-125: Viatris – Global Revenue (Billion US$), 2018 – 2022
Figure-126: Viatris – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-127: Sanofi – Global Revenue (Billion US$), 2018 – 2022
Figure-128: Sanofi – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-129: Amgen – Global Revenue (Billion US$), 2018 – 2022
Figure-130: Amgen – Forecast for Global Revenue (Billion US$), 2023 – 2028

List of Tables

Table-01: Global – Coronary Artery Disease Market Share by Country (Percent), 2018 – 2022
Table-02: Global – Forecast for Coronary Artery Disease Market Share by Country (Percent), 2023 – 2028
Table-03: Global – Coronary Artery Disease Market Share by Drug Type (Percent), 2018 – 2022
Table-04: Global – Forecast for Coronary Artery Disease Market Share by Drug Type (Percent), 2023 – 2028
Table-05: Global – Coronary Artery Disease Market Share by Distribution Channel (Percent), 2018 – 2022
Table-06: Global – Forecast for Coronary Artery Disease Market Share by Distribution Channel (Percent), 2023 – 2028